CN104800640A - Medicine for treating dysthymia - Google Patents
Medicine for treating dysthymia Download PDFInfo
- Publication number
- CN104800640A CN104800640A CN201510213834.5A CN201510213834A CN104800640A CN 104800640 A CN104800640 A CN 104800640A CN 201510213834 A CN201510213834 A CN 201510213834A CN 104800640 A CN104800640 A CN 104800640A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- dysthymia
- herba
- microlepia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating dysthymia. The medicine is prepared from the following crude drugs and pharmaceutically acceptable carriers in parts by weight: 250 parts of narrowleaf fig root and leaf, 220 parts of sapindus delavayi, 200 parts of microlepia marginat, 180 parts of metaplexis hemsleyana, 150 parts of ardisia quinquegona, 160 parts of ligularia japonica, 120 parts of bermuda grass, 100 parts of sida alnifolia, 100 parts of soroseris gillii and 80 parts of tadehagi triquetrum. The clinical application shows that the medicine for treating dysthymia has the advantages of rapid effect taking, remarkable treatment effect, good tolerance, low cost and no toxic or side effect.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicine for the treatment of dysthymia.
Background technology
Dysthymia be a class spirit easily excited and mental easily tired, to be often in a bad mood the neurosis disorder of worry and psychology physiological symptom.25% is had to be dysthymia patient in the patients with depression be in hospital undergoing treatment.Except the symptom of general depression, dysthymia also has oneself feature, as hallucination illusion, thus very thorny in clinical treatment treatment.
Summary of the invention
The object of this invention is to provide a kind of medicine for the treatment of dysthymia.
In order to realize object of the present invention, the invention provides a kind of medicine for the treatment of dysthymia, it is made up by weight of following bulk drugs and pharmaceutically acceptable carrier: Radix Fici Angustipoliae 250 parts, Semen Sapindi Delavayi 220 parts, Microlepia margihaea(Houee) C. Chr 200 parts, Herba seu Radix Metaplexis hemsleyanae 180 parts, Ardisia quinquegona 150 parts, rabbit hold up an umbrella 160 parts, Bermuda grass 120 parts, Folium sidae alnifoliae 100 parts, thin,tough silk hair chrysanthemum 100 parts and Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 80 parts.
Preferably, described medicine can make decoction.
The present invention also provides the purposes of compositions in the medicine of preparation treatment dysthymia, and described medicine is made up by weight of following bulk drugs and pharmaceutically acceptable carrier: Radix Fici Angustipoliae 250 parts, Semen Sapindi Delavayi 220 parts, Microlepia margihaea(Houee) C. Chr 200 parts, Herba seu Radix Metaplexis hemsleyanae 180 parts, Ardisia quinquegona 150 parts, rabbit hold up an umbrella 160 parts, Bermuda grass 120 parts, Folium sidae alnifoliae 100 parts, thin,tough silk hair chrysanthemum 100 parts and Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 80 parts.
In the present compositions, Radix Fici Angustipoliae is monarch drug, and Semen Sapindi Delavayi, Microlepia margihaea(Houee) C. Chr, Herba seu Radix Metaplexis hemsleyanae are ministerial drug, and Ardisia quinquegona, rabbit are held up an umbrella, Bermuda grass, Folium sidae alnifoliae, thin,tough silk Mao Juwei adjuvant drug, and Herba Desmodii Triquetri (Herba Tadehagi Triquetri) is for making medicine.
Use natural drug in the medicine for the treatment of dysthymia of the present invention, find through clinical practice, have effect rapidly, therapeutic effect obviously, better tolerance, advantage with low cost, without any side effects.
Detailed description of the invention
Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment decoction of the present invention
Get Radix Fici Angustipoliae 250 grams, Semen Sapindi Delavayi 220 grams, Microlepia margihaea(Houee) C. Chr 200 grams, Herba seu Radix Metaplexis hemsleyanae 180 grams, Ardisia quinquegona 150 grams, rabbit hold up an umbrella 160 grams, Bermuda grass 120 grams, Folium sidae alnifoliae 100 grams, thin,tough silk hair chrysanthemum 100 grams and Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 80 grams, add 25000 ml waters, heat 4 hours at 80 DEG C in sealed container.Be cooled to room temperature, filter, filtrate is medicine of the present invention.
Experimental example
Diagnostic criteria
" International Classification of Diseases-ten editions " that announce according to WHO and APA,American Psychiatric Association " mental disorder Diagnostic Statistical Manual-four editions " and Chinese Spirit Obstacles classification and the diagnostic criteria third edition (CCMD-3) diagnose dysthymia about the diagnostic criteria of depression, and get rid of organic disease.Degree of Depression is according to Hamilton depressive scale (HAMD) scoring (totally 24), wherein <8 is divided into normally, 8 ~ 18 are divided into minor depressive, and 18 ~ 24 are divided into modest depression, and >24 is divided into severe depression.HAMD scoring is see " psychiatric department evaluation charter " [M]. Changsha: Hunan science and technology publishing house, 1993,122nd ~ 203 pages.
Choose patient 80 example meeting above-mentioned standard, wherein man 50 example, female 30 example; 33 ~ 61 years old age, average 46 years old.
Decoction obtained in embodiment is used to treat, wherein one day 3 times, oral 100 milliliters at every turn, treatment 2 months continuously.
Criterion of therapeutical effect
HAMD scoring respectively before and after record treatment.With deduction rate >=75% for clinical recovery, with deduction rate >=50% for marked improvement, with deduction rate >=30% for progressive, be invalid with <30%.
Result
Through treatment, find the equal >75% of HAMD scoring deduction rate of all patients, therefore all meet the standard of clinical recovery.
Untoward reaction and toxic and side effects monitoring
By detect patient blood pressure, pulse, whether there is Nausea and vomiting, dizzy clinical symptoms judges untoward reaction.Setting human normal systolic pressure is between 90-140mmHg, diastolic pressure is between 60-90mmHg, human normal pulse is 60-100 beat/min, blood pressure, the pulse of patient is measured at treatments period, find that the blood pressure and pulse recorded is all within normal range, the phenomenon not exceeding normal interval occurs, and does not occur Nausea and vomiting, dizzy clinical symptoms.This illustrates that pharmaceutical composition of the present invention does not have obvious untoward reaction, and then proves that this medicine does not have obvious toxic and side effects for human body.
Claims (3)
1. treat the medicine of dysthymia for one kind, it is characterized in that, it is made up by weight of following bulk drugs and pharmaceutically acceptable carrier: Radix Fici Angustipoliae 250 parts, Semen Sapindi Delavayi 220 parts, Microlepia margihaea(Houee) C. Chr 200 parts, Herba seu Radix Metaplexis hemsleyanae 180 parts, Ardisia quinquegona 150 parts, rabbit hold up an umbrella 160 parts, Bermuda grass 120 parts, Folium sidae alnifoliae 100 parts, thin,tough silk hair chrysanthemum 100 parts and Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 80 parts.
2. the medicine for the treatment of dysthymia according to claim 1, is characterized in that, described medicine can make decoction.
3. the purposes of compositions in the medicine of preparation treatment dysthymia, it is characterized in that, described medicine is made up by weight of following bulk drugs and pharmaceutically acceptable carrier: Radix Fici Angustipoliae 250 parts, Semen Sapindi Delavayi 220 parts, Microlepia margihaea(Houee) C. Chr 200 parts, Herba seu Radix Metaplexis hemsleyanae 180 parts, Ardisia quinquegona 150 parts, rabbit hold up an umbrella 160 parts, Bermuda grass 120 parts, Folium sidae alnifoliae 100 parts, thin,tough silk hair chrysanthemum 100 parts and Herba Desmodii Triquetri (Herba Tadehagi Triquetri) 80 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510213834.5A CN104800640A (en) | 2015-04-30 | 2015-04-30 | Medicine for treating dysthymia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510213834.5A CN104800640A (en) | 2015-04-30 | 2015-04-30 | Medicine for treating dysthymia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104800640A true CN104800640A (en) | 2015-07-29 |
Family
ID=53686121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510213834.5A Pending CN104800640A (en) | 2015-04-30 | 2015-04-30 | Medicine for treating dysthymia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104800640A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169917A (en) * | 2012-12-09 | 2013-06-26 | 青岛百草汇中草药研究所 | Chinese medicinal composition for treating dysthymia and preparation method thereof |
| CN103705774A (en) * | 2013-12-30 | 2014-04-09 | 江苏省中医院 | Compound composition with effect of treating depression as well as preparation method and application thereof |
| CN103720791A (en) * | 2013-12-19 | 2014-04-16 | 柳州市中医院 | Zhuang nationality medicine for preventing and curing post-stroke depression and preparation method thereof |
-
2015
- 2015-04-30 CN CN201510213834.5A patent/CN104800640A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103169917A (en) * | 2012-12-09 | 2013-06-26 | 青岛百草汇中草药研究所 | Chinese medicinal composition for treating dysthymia and preparation method thereof |
| CN103720791A (en) * | 2013-12-19 | 2014-04-16 | 柳州市中医院 | Zhuang nationality medicine for preventing and curing post-stroke depression and preparation method thereof |
| CN103705774A (en) * | 2013-12-30 | 2014-04-09 | 江苏省中医院 | Compound composition with effect of treating depression as well as preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108042653A (en) | A kind of antifatigue inducing resuscitation plant cotton piece and its preparation process | |
| CN104189819B (en) | A kind of Chinese medicine preparation for being used to nurse one's health emotional health | |
| CN104800640A (en) | Medicine for treating dysthymia | |
| CN103622988B (en) | Cordycepin purposes in the medicine preparing depression and the Fast Anti antidepressant agents being prepared thereof | |
| CN101653474B (en) | Medicine for treating hemorrhoid and its preparing process | |
| CN110680880A (en) | Traditional Chinese medicine composition for treating liver-yang hyperactivity type insomnia and application thereof | |
| CN102204956A (en) | Chinese medicinal composition used at stroke recovery period and preparation method thereof | |
| CN102526248B (en) | Traditional Chinese medicine prescription capable of curing diabetes wound fester and continuously reducing blood sugar | |
| WO2011004910A1 (en) | Glycyrrhizin as restorative agent for antimicrobial peptide production ability | |
| CN104825869B (en) | A kind of medicine for the treatment of anxiety neurosis | |
| CN104771560B (en) | A kind of medicine for the treatment of mania | |
| CN105998335A (en) | Tranquilizing traditional Chinese medicine composition gel and preparation method thereof | |
| CN103550459B (en) | A kind of preparation method for the treatment of the medicament of infantile asthma | |
| CN104127548B (en) | Pharmaceutical composition for treating viral myocarditis in children | |
| CN102961725B (en) | Agentia for treating dysthymia | |
| CN104800437B (en) | One treats schizoid medicine | |
| CN104664533A (en) | Preparation method of health beverage | |
| Henson | Zembrin Sceletium Extract Shown Safe in Trial in Healthy Adults. | |
| CN103041351A (en) | Decoction for treating dysthymia | |
| CN115252594A (en) | Application of sanshool in preparation of medicine for resisting propionibacterium acnes | |
| CN103251882A (en) | Pharmaceutical composition for treating tumor | |
| TWI224005B (en) | Pharmaceutical composition for nasal spray in treatment of cold and fever and method for producing the same | |
| WO2006029550A1 (en) | Hemostatic mistura of ipomoea balatas leaves, methods of preparation and use thereof | |
| CN103550519A (en) | Preparation method of medicament for treating dysmenorrhea | |
| CN116898891A (en) | Traditional Chinese medicine composition for resisting anxiety disorder and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150729 |